Novolin 70/30 and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Novolin 70/30 (insulin recombinant purified human; insulin susp isophane semisynthetic purified human), especially for people who are female, 60+ old, also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Rashes when taking Novolin 70/30. It is created by eHealthMe based on reports of 1,581 people who have side effects when taking Novolin 70/30 from the FDA, and is updated regularly.

What is Novolin 70/30?

Novolin 70/30 has active ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human. It is often used in diabetes. eHealthMe is studying from 1,611 Novolin 70/30 users. Check the latest studies of Novolin 70/30.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 10, 2026

1,581 people reported to have side effects when taking Novolin 70/30.
Among them, 27 people (1.71%) have Rashes.

Among these 27 people:

What is the gender of people who have Rashes when taking Novolin 70/30? *

female: 62.96 %
male: 37.04 %

What is the age of people who have Rashes when taking Novolin 70/30? *

What are other drugs people take besides Novolin 70/30? *

What are other side effects people have besides Rashes? *

Itching: 8 people, 29.63%
Blood Glucose Decreased: 5 people, 18.52%
Pain: 4 people, 14.81%
Blood Glucose Increased: 3 people, 11.11%
Dyspnea (difficult or laboured breathing): 3 people, 11.11%
Peripheral Swelling: 3 people, 11.11%
Nausea (feeling of having an urge to vomit): 3 people, 11.11%
Nausea And Vomiting: 3 people, 11.11%
Constipation: 2 people, 7.41%
Chest Pain: 2 people, 7.41%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 18.52%
High Blood Cholesterol: 3 people, 11.11%
Neuropathy Peripheral (surface nerve damage): 2 people, 7.41%
Nausea (feeling of having an urge to vomit): 2 people, 7.41%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.41%
Cardiac Failure Congestive: 1 person, 3.70%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.70%
Depression: 1 person, 3.70%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.70%
Dizziness: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Novolin 70/30 and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolin 70/30:

Novolin 70/30 (1,611 reports)

Rashes treatments and more:

Rashes (702,909 reports)

How severe was Rashes and when was it recovered:

Rashes in Novolin 70/30

Expand to all the drugs that have ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human:

Rashes and drugs with ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novolin 70/30:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant purified human; insulin susp isophane semisynthetic purified human (the active ingredients of Novolin 70/30) and Novolin 70/30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.